Grass pollen nasal challenge is associated with increases in Th2 cytokines, Eotaxin, MDC and IL-6 in nasal fluid

Documenti analoghi

• Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
  di: Scadding, G. W., et al.
  Pubblicazione: (2015)
• Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes
  di: Steveling, Esther Helen, et al.
  Pubblicazione: (2015)
• Effect of Two Years of Treatment with Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at Three Years among Patients with Moderate to Severe Seasonal Allergic Rhinitis: A Randomized Clinical Trial: The GRASS Randomized Clinical Trial
  di: Scadding, Guy W., et al.
  Pubblicazione: (2017)
• Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
  di: Penagos, Martin, et al.
  Pubblicazione: (2018)
• Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1 : Th2 cytokine ratios
  di: Wachholz, Petra A, et al.
  Pubblicazione: (2002)